Blocking the action of calcium signals in immune cells suppresses the most common form of asthma, but without compromising the body's defenses against flu viruses, a new study finds.
Oct 7, 2022
0
115
A study of school children conducted by University of Rochester Medical Center researchers has found that the majority of children with asthma also reported having allergic rhinitis, or hay fever. Symptoms of hay fever include ...
Sep 17, 2022
0
13
An intensive training schedule is linked to a heightened risk of non-allergic asthma in competitive cross-country skiers, finds research published in the open access journal BMJ Open Sports & Exercise Medicine.
Jun 13, 2022
0
2
When most people think of cardiovascular diseases (CVD), risk factors such as high blood pressure, high cholesterol, obesity, and diabetes likely come to mind. But mounting evidence from both basic research and clinical studies ...
May 16, 2022
0
100
A study with more than 8,700 participants from 11 European countries and Australia has concluded that adults with asthma are more likely to become obese later in life. The research, led by the Barcelona Institute of Global ...
Apr 27, 2022
0
4
One in every nine people in Australia has asthma. It is a health burden for many children, and expensive for families because of medication, hospital and out-of-hospital expenses.
Feb 18, 2022
0
6
Studies have shown that climate change has been partly responsible for longer growing seasons and larger pollen loads, leading to speculation of an increase in sensitizations to environmental allergens. A new study being ...
Nov 5, 2021
0
1
Bronchial asthma causes symptoms such as wheezing and cough due to chronic airway inflammation, but there is no fundamental treatment for it, leaving a desire for new prevention and treatment methods. Now a new study reveals ...
Oct 26, 2021
0
1
Mast cell precursor cells do not just cause an increase in mature mast cells during inflammation, they also play an active role in diseases like asthma. This finding is in a new study by immunology researchers published in ...
Sep 27, 2021
0
66
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic ...
May 17, 2021
0
199
